Ototoxicity associated with intravenous bisphosphonate administration.

Reid, I R; Mills, D A; Wattie, D J · Calcif Tissue Int · 1995

case_report · Level V

Where this comes from

Abstract

The development of ototoxicity in association with intravenous pamidronate treatment of Paget's disease is described. The patient developed hearing loss, vertigo, and tinnitus which were exacerbated by subsequent infusions. This potentially serious drug side-effect does not appear to have been reported previously in patients with Paget's disease.

Medical subject headings